µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£© )b
=$!
}, ]W/
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© 1:,aFp>qr
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© p~r +2(J
1.Co-stimulators (or co-stimulating molecules) *P_TG"^{W
2.NK-kB 43/|[
3.Immunoglobulin superfamily `0sa94H1[
4.antigen-presenting cell (APC) O9opX\9
5.death domain Tj>~#~
6.CCR and CXCR q*
m%Fv
7.Lectin (or mitogen) %1#5
7-
8.Clusters of differentiation, CD) KB-7]H
9.B7 family nGRF<2!
10.Cytotoxic T lymphocyte, CTL) Jx'p\*
11.IL-15 and IL-15 receptor (IL-15R) )9Jt550(
12.MHC restriction 8zr)oQ:
13.Affinity-chromatography ed&,
14.Cyctosprin A, CsA +('jqbV
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) [u~#F,_ow
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© GXsHc,
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 ?+51 B-
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ bj7v <G|Y
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢á¹¹¼°Æäʶ±?¿¹ÔµÄÌØµã¡£ 5HmX-+XpK
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© x3)qK6,\
ÃâÒßѧרҵ£º [
h%ci3
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ 37{mhU
Ïû»¯ÄÚ¿Æ£º Byon2| nf7
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ H]YPMG<
ѪҺ²¡Ñ§×¨Òµ£º l^fz
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿